Your browser doesn't support javascript.
loading
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma.
Grunenberg, Alexander; Kaiser, Lisa M; Woelfle, Stephanie; Schmelzle, Birgit; Viardot, Andreas; Möller, Peter; Barth, Thomas Fe; Muche, Rainer; Dreyhaupt, Jens; Buske, Christian.
Afiliación
  • Grunenberg A; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Kaiser LM; Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.
  • Woelfle S; Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.
  • Schmelzle B; Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.
  • Viardot A; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Möller P; Institute of Pathology, Ulm University, Ulm, Germany.
  • Barth TF; Institute of Pathology, Ulm University, Ulm, Germany.
  • Muche R; Institute of Epidemiology & Medical Biometry, Ulm University, Ulm, Germany.
  • Dreyhaupt J; Institute of Epidemiology & Medical Biometry, Ulm University, Ulm, Germany.
  • Buske C; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
Future Oncol ; 16(13): 817-825, 2020 May.
Article en En | MEDLINE | ID: mdl-32223334
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B de la Zona Marginal / Antígenos CD20 / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Future Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B de la Zona Marginal / Antígenos CD20 / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adolescent / Female / Humans / Male Idioma: En Revista: Future Oncol Año: 2020 Tipo del documento: Article País de afiliación: Alemania